AIMS: Platelets are a natural source of growth factors, cytokines and chemokines, that regulate angiogenesis and inflammation. It has been suggested that differential release of pro- and anti-angiogenic growth factors from platelet α-granules by protease-activated receptors (PAR) 1 and 4 may be important for the regulation of angiogenesis. We aimed to compare the releasates of unstimulated platelets with PAR-1- and PAR-4-stimulated platelets. METHODS AND RESULTS: The release of β-thromboglobulin, platelet factor (PF)-4, thrombospondin, platelet-derived growth factor (PDGF)-A/B, regulated and normal T-cell expressed and secreted (RANTES/CCL5), endostatin, CXCL12, and vascular endothelial growth factor (VEGF) was measured with enzyme-linked i...
Thrombin is the key serine protease of the coagulation cascade and a potent trigger of protease-acti...
The in vivo study of protease activated receptors (PARs) in platelets is complicated due to species ...
Anti-platelet drugs are the mainstay of pharmacotherapy for heart attack and stroke prevention, yet ...
<div><p></p><p><i>Background</i>: Platelets mediate angiogenesis through the secretion of several fa...
Category: Basic Sciences/Biologics Introduction/Purpose: Tendon injuries occur frequently and cost b...
Human platelets express two protease-activated receptors (PARs), PAR1 (F2R) and PAR4 (F2RL3), which ...
Essentials: The platelet thrombin receptor, PAR4, is an emerging anti-thrombotic drug target. We exa...
Platelet-derived MPs (PMPs) are a heterogeneous population of microvesicles released from platelets ...
BACKGROUND: Thrombin-induced platelet activation is important for arterial thrombosis. Thrombin acti...
Thrombin is the key serine protease of the coagulation cascade and a potent trigger of protease-acti...
Thrombin is a pivotal enzyme formed in the coagulation cascade and an important and potent platelet ...
Thrombin is a pivotal enzyme formed in the coagulation cascade and an important and potent platelet ...
Thrombin is a pivotal enzyme formed in the coagulation cascade and an important and potent platelet ...
PURPOSE: Platelet-endothelial cell adhesion is an important pathologic response to vessel injury or ...
With the recent interest of protease-activated receptors (PAR) 1 and PAR4 as possible targets for th...
Thrombin is the key serine protease of the coagulation cascade and a potent trigger of protease-acti...
The in vivo study of protease activated receptors (PARs) in platelets is complicated due to species ...
Anti-platelet drugs are the mainstay of pharmacotherapy for heart attack and stroke prevention, yet ...
<div><p></p><p><i>Background</i>: Platelets mediate angiogenesis through the secretion of several fa...
Category: Basic Sciences/Biologics Introduction/Purpose: Tendon injuries occur frequently and cost b...
Human platelets express two protease-activated receptors (PARs), PAR1 (F2R) and PAR4 (F2RL3), which ...
Essentials: The platelet thrombin receptor, PAR4, is an emerging anti-thrombotic drug target. We exa...
Platelet-derived MPs (PMPs) are a heterogeneous population of microvesicles released from platelets ...
BACKGROUND: Thrombin-induced platelet activation is important for arterial thrombosis. Thrombin acti...
Thrombin is the key serine protease of the coagulation cascade and a potent trigger of protease-acti...
Thrombin is a pivotal enzyme formed in the coagulation cascade and an important and potent platelet ...
Thrombin is a pivotal enzyme formed in the coagulation cascade and an important and potent platelet ...
Thrombin is a pivotal enzyme formed in the coagulation cascade and an important and potent platelet ...
PURPOSE: Platelet-endothelial cell adhesion is an important pathologic response to vessel injury or ...
With the recent interest of protease-activated receptors (PAR) 1 and PAR4 as possible targets for th...
Thrombin is the key serine protease of the coagulation cascade and a potent trigger of protease-acti...
The in vivo study of protease activated receptors (PARs) in platelets is complicated due to species ...
Anti-platelet drugs are the mainstay of pharmacotherapy for heart attack and stroke prevention, yet ...